Amikacin Liposome Inhalation Suspension as a Treatment Option for Refractory Nontuberculous Mycobacterial Lung Disease Caused by Mycobacterium avium Complex/Reply

Saved in:
Bibliographic Details
Published inMayo Clinic proceedings Vol. 95; no. 1; pp. 201 - 202
Main Authors Swenson, Colin, Del Parigi, Angelo, Shulha, Jennifer
Format Journal Article
LanguageEnglish
Published Rochester Elsevier Limited 01.01.2020
Subjects
Amikacin
Drug therapy
FDA approval
Inhalation
Lung diseases
Atlanta Georgia
Online AccessGet full text

Cover

More Information
ISSN:0025-6196